… inhaler.3, 4 However, with the introduction of nebulizers, two reports of acute glaucoma
following nebulized bronchodilator therapy … glaucoma caused by nebulized ipratropium bromide. …

… ocular deposition of nebulized medication.2, 3 Protective eyewear may offer additional
protection to those at risk for angle-closure glaucoma who require nebulized albuterol therapy. …

… two cases of fixed dilated pupils after nebulized … closure glaucoma following treatment with
nebulized ipratropium alone and one report of acute glaucoma after treatment with nebulized …

… cases have occurred in hospitalized patients receiving continuing nebulized therapy. A
66-… -closure glaucoma less than 48 hours after successful treatment with nebulized albuterol …

… This case report highlights this rare but possible side effect of inhaled bronchodilator therapy.
Health care providers need to be aware of this uncommon adverse effect and appropriate …

… bronchodilator therapy for at least 1 year. The study excluded patients with diabetes, collagen
vascular disease, glaucoma, a … bronchodilators or corticosteroids via nebulizer but not …

… of nebulized ipratropium bromide and albuterol … Patients were excluded from study if they
had a history of severe eye injury or congenital eye disorders, including congenital glaucoma…

… Bronchodilator therapy was administered via nebulizer, driven … In addition, all patients received
an IV bolus of 125 mg of … ; receiving treatment for or suspected of having glaucoma, three; …

… patient as having OAD only by the presence of inhaler prescriptions without a diagnosis of
OAD, as inhaler … No risk was found among patients previously untreated with bronchodilators. …

… 1 Beneficial effects of maintenance bronchodilator therapy on exercise tolerance, quality of
life, … , recent upper or lower respiratory tract infection, or a history of narrowangle glaucoma. …